Ezetimibe CAS : 163222-33-1 GMP DMF
Name : Ezetimibe
CAS No . : 163222-33-1
Chemical Name : ( 3R , 4S ) - 1 - ( 4 - fluorophenyl ) - 3 - [ ( 3S ) - 3 - ( 4 - fluorophenyl ) - 3 - hydroxypropyl ] - 4 - ( 4 -
hydroxyphenyl )azetidin - 2 - one
Molecular Formula : C24H21F2NO3
Molecular Weight : 409.4
Description: Ezetimibe is the active pharmaceutical ingredient (API) of branded
drug Zetia, or one of the active pharmaceutical ingredients (API)
of branded drug Liptruzet (the other API is atorvastatin) or
Vytorin (the other API is simivastatin). It was innovated by
Schering-Plough Pharmaceuticals and co-marketed with Merck/MSD.
Ezetimibe is used to reduce the amount of cholesterol and other
fatty substances in the blood. It may be used alone or with other
statins such as atorvastatin and simivastatin.
The drug might be protected by patents in some courtires or areas.
We only sell it to non patent protected countries or areas. The
sale to patent protection countries and areas is only for R & D
purpose. The buyers should take all responsiblity of patent status
in his countries or areas.
Competitive Advantage: Produced under cGMP conditions, support